JPRN-UMIN000028669已完成未知
Effects and safety of ferric citrate hydrate in patients with receiving hemodialysis. - Effects and safety of ferric citrate hydrate in patients with receiving hemodialysis.
Tomei-Atsugi Hospital0 个研究点目标入组 30 人开始时间: 2017年8月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •AST,ALT over100 IU/L. Allergy to riona. Pregnant or possible pregnancy. Inappropriate patients regarded by doctor.
研究者
相似试验
已完成
不适用
Clinical evaluation of the effect of ferric citrate hydrate in hemodialysis patients with renal anemia and hyperphosphatemiaJPRN-UMIN000025478Saiseikai Kumamoto Hospital80
已完成
不适用
The efficacy of ferric citrate hydrate in chronic kidney disease with mild hyperphosphatemia: randomized controlled open-labeled trialpredialysis chronic kidney disease (predialysis CKD)JPRN-UMIN000018118Osaka Medical College, department of Internal Medicine 340
已完成
不适用
A prospective study for the effect of ferric citrate on FGF23 in patients with normophosphatemic CKD patients with iron deficiency.chronic kidney diseaseJPRN-UMIN000020935Department of Nephrology and Rheumatology, Saiseikai Niigata Daini Hospital60
招募中
Unknown
Efficacy of ferric citrate hydrate in chronic heart failure complicated with iron deficiency anaemia.chronic heart failure with Iron deficiency anaemiaJPRN-UMIN000050436Sekino Hospital100
已完成
不适用
Efficacy and safety of phosphate binders, ferric citrete hydrate and lanthunam carbohydrate, in patients undergoing maintenance hemodialysisJPRN-UMIN000021818Divisions of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine60